Found: 15
Select item for more details and to access through your institution.
ALSFRS-R-SE: an adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scale.
- Published in:
- Neurological Research & Practice, 2022, v. 4, n. 1, p. 1, doi. 10.1186/s42466-022-00224-6
- By:
- Publication type:
- Article
Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials.
- Published in:
- Translational Neurodegeneration, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40035-021-00257-y
- By:
- Publication type:
- Article
Multiomics and machine-learning identify novel transcriptional and mutational signatures in amyotrophic lateral sclerosis.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 9, p. 3770, doi. 10.1093/brain/awad075
- By:
- Publication type:
- Article
Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With Nusinersen.
- Published in:
- Frontiers in Neurology, 2019, v. 10, p. 1, doi. 10.3389/fneur.2019.01179
- By:
- Publication type:
- Article
Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen.
- Published in:
- Journal of Neurology, 2020, v. 267, n. 1, p. 36, doi. 10.1007/s00415-019-09547-y
- By:
- Publication type:
- Article
Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients.
- Published in:
- Journal of Neurology, 2019, v. 266, n. 1, p. 183, doi. 10.1007/s00415-018-9124-0
- By:
- Publication type:
- Article
Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2019, p. N.PAG, doi. 10.1177/1756286419846058
- By:
- Publication type:
- Article
ALS is imprinted in the chromatin accessibility of blood cells.
- Published in:
- Cellular & Molecular Life Sciences, 2023, v. 80, n. 5, p. 1, doi. 10.1007/s00018-023-04769-w
- By:
- Publication type:
- Article
Clinical and genetic features of amyotrophic lateral sclerosis patients with C9orf72 mutations.
- Published in:
- Brain Communications, 2023, v. 5, n. 2, p. 1, doi. 10.1093/braincomms/fcad087
- By:
- Publication type:
- Article
Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis.
- Published in:
- JAMA Neurology, 2022, v. 79, n. 2, p. 121, doi. 10.1001/jamaneurol.2021.4893
- By:
- Publication type:
- Article
Low T-cell reactivity to TDP-43 peptides in ALS.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1193507
- By:
- Publication type:
- Article
Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Quality of Life in SMA Patients Under Treatment With Nusinersen.
- Published in:
- Frontiers in Neurology, 2021, v. 11, p. N.PAG, doi. 10.3389/fneur.2021.626787
- By:
- Publication type:
- Article
Longitudinal course of neurofilament light chain levels in amyotrophic lateral sclerosis—insights from a completed randomized controlled trial with rasagiline.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 3, p. 1, doi. 10.1111/ene.16154
- By:
- Publication type:
- Article
Mutation‐specific metabolic profiles in presymptomatic amyotrophic lateral sclerosis.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 1, p. 87, doi. 10.1111/ene.15584
- By:
- Publication type:
- Article